首页|IL-18和IL-18结合蛋白在骨髓增生异常综合征中的临床意义

IL-18和IL-18结合蛋白在骨髓增生异常综合征中的临床意义

Clinical significance of IL-18 and IL-18-binding protein in bone marrow of patients with myelodys-plastic syndrome

扫码查看
原文链接
  • NETL
  • NSTL
  • 维普
  • 万方数据
目的 分析IL-18、IL-18结合蛋白(IL-18BP)在骨髓增生异常综合征(MDS)患者骨髓液中的表达水平及临床意义.方法 纳入2020年7月至2021年2月天津医科大学总医院血液科收治的初诊MDS患者43例,对照组包括急性髓系白血病(AML)患者14例、缺铁性贫血(IDA)患者25例,检测骨髓上清中IL-18和IL-18BP水平,分析其与MDS的严重程度、CD8+T细胞及NK细胞功能的相关性.结果 MDS患者骨髓上清中IL-18、IL-18BP和游离IL-18(fIL-18)的水平均高于IDA组,fIL-18的水平与MDS-IPSS评分呈线性负相关.MDS患者CD8+T细胞表面IL-18受体(IL-18Rα)表达低于IDA组,fIL-18及IL-18Rα水平均与MDS患者CD8+T细胞功能呈正相关.结论 IL-18在MDS患者骨髓微环境中表达增加,但由于IL-18BP的存在导致fIL-18相对减少,与MDS疾病严重程度和CD8+T细胞功能减低有关.
Objective To analyze the level and clinical significance of IL-18 and IL-18-binding protein(BP)in the bone marrow of patients with myelodysplastic syndrome(MDS).Methods A total of 43 newly diagnosed patients with MDS who were admitted to the Department of Hematology,Tianjin Medical University General Hospital,from July 2020 to February 2021 were randomly selected.The control group consisted of 14 patients with acute myeloid leukemia(AML)and 25 patients with iron-deficiency anemia(IDA).The levels of IL-18 and IL-18 BP in the bone marrow supernatant were measured,and their correlations with MDS severity,as well as the functionality of CD8+T cells and natural killer cells,was analyzed.Results The levels of IL-18,IL-18 BP,and free IL-18(fIL-18)in the bone marrow supernatant of patients with MDS were higher than in the IDA group.The level of fIL-18 was linearly and negatively correlated with the MDS-International Prognostic Scoring System(IPSS)score.IL-18 receptor(IL-18Rα)expression on CD8+T cells in the MDS group was lower than in the IDA group,and the levels of fIL-18 and IL-18Rα were positively correlated with CD8+T-cell function in the MDS group.Conclusion IL-18 BP antagonizes IL-18,leading to a decrease in fIL-18 in the bone marrow microenvironment of patients with MDS,affecting CD8+T-cell function,which is closely related to MDS severity;therefore,it may become a new target for MDS treatment.

Myelodysplastic syndromeIL-18IL-18-binding proteinFree IL-18

王婷、冉柠源、陈邱林、刘冬兰、臧梦桐、李念滨、贺欣、关晶、付蓉、邵宗鸿

展开 >

天津医科大学总医院,天津 300052

天津市骨髓衰竭及癌性造血克隆防治重点实验室,天津 300052

中南大学湘雅医学院附属常德医院(常德市第一人民医院)血液内科,常德 415003

北京朝阳医院肾内科,北京 100020

展开 >

骨髓增生异常综合征 IL-18 IL-18结合蛋白 游离IL-18

国家自然科学基金国家自然科学基金天津市自然科学基金天津市卫生健康委科技攻关计划天津市医疗健康学会项目天津市医疗健康学会项目天津市医疗健康学会项目

819701158197011618JCYBJC2720016KG124TJSYLJKXH004TJSYL-JKXH002TJSYLJKXH013

2024

10.3760/cma.j.cn121090-20231009-00178

中华血液学杂志
中华医学会

中华血液学杂志

CSTPCD北大核心
影响因子：1.17
ISSN：0253-2727
年,卷(期)：2024.45(3)
  • 19